<DOC>
	<DOCNO>NCT01553500</DOCNO>
	<brief_summary>Non-alcoholic fatty liver disease ( NAFLD ) reach epidemic proportion rapidly become one common cause chronic liver disease child . The pathogenesis NAFLD generally consider result series liver injury , commonly refer `` multi-hit '' hypothesis . Insulin resistance increase serum level free fatty acid ( FFAs ) consider main primary hit lead excessive lipid accumulation hepatocytes result steatosis . Has report diet rich high-viscosity fiber improve glycemic control lipid profile , suggest therapeutic potential role treatment NAFLD . Aim study evaluate efficacy tolerability glucomannan child affect non alcoholic fatty liver disease .</brief_summary>
	<brief_title>Glucomannan Effects Children With Non-alcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>( 1-6 ) -alpha-glucomannan</mesh_term>
	<criteria>informed consent parent legal tutor ALT level &lt; 10 ULN hyperechogenicity liver ultrasound examination suggestive fatty liver INR &lt; 1,3 Albumin &gt; 3 g/dl total bilirubin &lt; 2,5 mg/dl previous gastrointestinal bleeding previous portosystemic encephalopathy normal renal function HIVHCVHDV infection normal cell blood count every clinical psychiatric disease interfere experimentation accord investigator 's evaluation find active liver disease due cause corticosteroid , immunosuppressive drug chemotherapy 2 month study alcohol consumption use drug know induce steatosis affect body weight carbohydrate metabolism find actual previous level alphafetoprotein &gt; 50 ng/ml hepatocellular carcinoma diabetes mellitus type I</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>child</keyword>
</DOC>